Subscribe To
Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit
BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Laurence Reid, Ph.D., Chief Executive Officer, will participate in a fireside chat at the Barclays 2023 Gene Editing and Gene Therapy Summit on […] The post Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy...
Read More
Posted: May 17 2023, 20:30
Author Name: forextv
Views: 081575